Cargando…
Development of an advanced cell therapy product indicated for the treatment of gonarthrosis
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685328/ http://dx.doi.org/10.1186/1753-6561-9-S9-O9 |
_version_ | 1782406296720375808 |
---|---|
author | Vives, Joaquim Blanco, Margarita Caminal, Marta Coca, Maria I Codinach, Margarita Coll, Ruth Doral, Manuel Lloret, Mireia Oliver-Vila, Irene Ortega, Isabel Reales, Laura Requena-Montero, Míriam Rodríguez, Luciano Torrents, Sílvia García, Joan |
author_facet | Vives, Joaquim Blanco, Margarita Caminal, Marta Coca, Maria I Codinach, Margarita Coll, Ruth Doral, Manuel Lloret, Mireia Oliver-Vila, Irene Ortega, Isabel Reales, Laura Requena-Montero, Míriam Rodríguez, Luciano Torrents, Sílvia García, Joan |
author_sort | Vives, Joaquim |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4685328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46853282015-12-28 Development of an advanced cell therapy product indicated for the treatment of gonarthrosis Vives, Joaquim Blanco, Margarita Caminal, Marta Coca, Maria I Codinach, Margarita Coll, Ruth Doral, Manuel Lloret, Mireia Oliver-Vila, Irene Ortega, Isabel Reales, Laura Requena-Montero, Míriam Rodríguez, Luciano Torrents, Sílvia García, Joan BMC Proc Oral Presentation BioMed Central 2015-12-14 /pmc/articles/PMC4685328/ http://dx.doi.org/10.1186/1753-6561-9-S9-O9 Text en Copyright © 2015 Vives et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Oral Presentation Vives, Joaquim Blanco, Margarita Caminal, Marta Coca, Maria I Codinach, Margarita Coll, Ruth Doral, Manuel Lloret, Mireia Oliver-Vila, Irene Ortega, Isabel Reales, Laura Requena-Montero, Míriam Rodríguez, Luciano Torrents, Sílvia García, Joan Development of an advanced cell therapy product indicated for the treatment of gonarthrosis |
title | Development of an advanced cell therapy product indicated for the treatment of gonarthrosis |
title_full | Development of an advanced cell therapy product indicated for the treatment of gonarthrosis |
title_fullStr | Development of an advanced cell therapy product indicated for the treatment of gonarthrosis |
title_full_unstemmed | Development of an advanced cell therapy product indicated for the treatment of gonarthrosis |
title_short | Development of an advanced cell therapy product indicated for the treatment of gonarthrosis |
title_sort | development of an advanced cell therapy product indicated for the treatment of gonarthrosis |
topic | Oral Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685328/ http://dx.doi.org/10.1186/1753-6561-9-S9-O9 |
work_keys_str_mv | AT vivesjoaquim developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT blancomargarita developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT caminalmarta developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT cocamariai developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT codinachmargarita developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT collruth developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT doralmanuel developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT lloretmireia developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT olivervilairene developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT ortegaisabel developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT realeslaura developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT requenamonteromiriam developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT rodriguezluciano developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT torrentssilvia developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis AT garciajoan developmentofanadvancedcelltherapyproductindicatedforthetreatmentofgonarthrosis |